Garbutt Jane M, Freiner Donna, Highstein Gabrielle R, Nelson Kyle A, Smith Sharon R, Strunk Robert C
Department of Pediatrics, Washington University School of Medicine, St Louis, Missouri, USA.
Ann Allergy Asthma Immunol. 2009 Jun;102(6):504-9. doi: 10.1016/S1081-1206(10)60125-1.
To reduce symptoms and emergency department (ED) visits, the National Asthma Education and Prevention Program (NAEPP) guidelines recommend early treatment of acute asthma symptoms with albuterol and oral corticosteroids. Yet, ED visits for asthma are frequent and often occur several days after onset of increased symptoms, particularly for children from low-income, urban neighborhoods.
To describe home use of albuterol and identify factors associated with appropriate albuterol use.
A total of 114 caregivers in the intervention group of a randomized trial to reduce emergent care for low-income, urban children completed a structured telephone interview with an asthma nurse to evaluate home management of their child's acute asthma symptoms. Interviews lasted approximately 20 minutes and were conducted from November 5, 2003, through September 30, 2005. Albuterol use as reported by caregivers was categorized as appropriate or inappropriate based on NAEPP recommendations.
Albuterol use for worsening asthma symptoms was categorized as appropriate for only 68% of caregivers and was more likely if the children had an ED visit or hospitalization for asthma in the prior year. The remaining 32% of caregivers used albuterol inappropriately (overtreatment or undertreatment). Appropriate albuterol use was not associated with caregiver report of having an asthma action plan (AAP) or a recent primary care physician visit to discuss asthma maintenance care.
Caregivers reported that they would use albuterol to treat their child's worsening asthma symptoms, but many described inappropriate use. Detailed evaluation of proper albuterol use at home may provide insight into how health care professionals can better educate and support parents in their management of acute exacerbations and more effective use of AAPs.
为减轻症状并减少急诊科就诊次数,国家哮喘教育与预防计划(NAEPP)指南建议使用沙丁胺醇和口服糖皮质激素对急性哮喘症状进行早期治疗。然而,哮喘患者的急诊科就诊仍然频繁,且往往在症状加重数天后才出现,尤其是来自低收入城市社区的儿童。
描述沙丁胺醇的家庭使用情况,并确定与沙丁胺醇合理使用相关的因素。
一项旨在减少低收入城市儿童急诊护理的随机试验干预组中的114名护理人员,与一名哮喘护士进行了结构化电话访谈,以评估其对孩子急性哮喘症状的家庭管理情况。访谈持续约20分钟,于2003年11月5日至2005年9月30日进行。护理人员报告的沙丁胺醇使用情况根据NAEPP建议分为适当或不适当。
仅68%的护理人员将用于哮喘症状恶化的沙丁胺醇使用归类为适当,如果孩子上一年因哮喘到急诊科就诊或住院,则更有可能适当使用。其余32%的护理人员沙丁胺醇使用不当(治疗过度或治疗不足)。沙丁胺醇的合理使用与护理人员报告有哮喘行动计划(AAP)或最近因讨论哮喘维持治疗而就诊于初级保健医生无关。
护理人员报告他们会使用沙丁胺醇治疗孩子恶化的哮喘症状,但许多人描述了不当使用情况。对家庭中沙丁胺醇合理使用情况的详细评估,可能有助于深入了解医疗保健专业人员如何更好地教育和支持家长管理急性加重情况以及更有效地使用哮喘行动计划。